Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • SGLT
    (2)
TargetMol | Tags By ResearchField
  • Endocrine system
    (1)
  • Metabolism
    (1)
Filter
Search Result
Results for "

remogliflozin etabonate

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    2
    TargetMol | All_Pathways
  • Isotope Products
    1
    TargetMol | Isotope_Products
Remogliflozin etabonate
GSK-189075A, GSK189075A, GSK-189075, GSK189075, GSK 189075A, GSK 189075
T34286442201-24-3
Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively.
  • $30
In Stock
Size
QTY
Remogliflozin etabonate-d7
GSK189075-d7
TMIT-01131233515-93-9
Remogliflozin etabonate-d7 (GSK189075-d7) is a deuterium-labeled form of Remogliflozin etabonate. Remogliflozin etabonate (GSK189075), an orally active, selective, and low-affinity sodium-glucose co-transporter (SGLT2) inhibitor, exhibits Ki values of 1.95 μM for hSGLT2, 43.1 μM for rSGLT2, 2.14 μM for hSGLT1, and 8.57 μM for rSGLT1. As a benzylpyrazole glucoside-based prodrug, it is metabolized in vivo to its active form, Remogliflozin, and demonstrates antidiabetic efficacy in rodent models.
  • Inquiry Price
Inquiry
Size
QTY